Investor Presentaiton

t EST 1 Diversified pipeline offering multiple near-term catalysts Product Indication Preclinical Phase I Phase II Phase III Commercialization ESTELLEⓇ Contraception e DONESTAⓇ Menopause Endometriosis; CSF-1R cancer; inflammatory disorders N MYRING® Contraception V a TIBELIA® Menopause ZORELINE® n Oncology Mithra Investor Presentation - November 2023 6

View entire presentation